Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Sep;33(9):1600–1605. doi: 10.1128/aac.33.9.1600

Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitro.

J M Hu 1, G D Hsiung 1
PMCID: PMC172709  PMID: 2817855

Abstract

Two new antiviral agents, compound 164, also known as 2'-nor-cGMP (9-[(2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl]-guani ne P-oxide), and compound 102 [4-amino-5-bromo-7-(2-hydroxyethoxymethyl)-pyrrolo(2,3-d)pyrimidine], together with acyclovir for comparison, were evaluated for activities against the guinea pig lymphotropic herpesvirus infection in vitro by plaque reduction and virus yield reduction assays in guinea pig embryo cells. The two new compounds were demonstrated to be more potent against guinea pig lymphotropic herpesvirus infections than acyclovir. Compound 164 was the most potent of the three; drug concentrations required to reduce the number of plaques by 50% were 2, 35.5, and 144.5 microM for compounds 164, 102, and acyclovir, respectively. The two new compounds were cytostatic but not cytotoxic to guinea pig embryo cells in cultures. Attempts were made to investigate the inhibition of viral replication by these compounds, and the influence of test conditions on antiviral evaluations is discussed.

Full text

PDF
1600

Images in this article

1603Image
on p.1603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amtmann E., Müller-Decker K., Hoss A., Schalasta G., Doppler C., Sauer G. Synergistic antiviral effect of xanthates and ionic detergents. Biochem Pharmacol. 1987 May 1;36(9):1545–1549. doi: 10.1016/0006-2952(87)90124-9. [DOI] [PubMed] [Google Scholar]
  2. Boyd M. R., Bacon T. H., Sutton D., Cole M. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture. Antimicrob Agents Chemother. 1987 Aug;31(8):1238–1242. doi: 10.1128/aac.31.8.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen M., Griffith B. P., Lucia H. L., Hsiung G. D. Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother. 1988 May;32(5):678–683. doi: 10.1128/aac.32.5.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheng Y. C., Grill S., Ruth J., Bergstrom D. E. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy. Antimicrob Agents Chemother. 1980 Dec;18(6):957–961. doi: 10.1128/aac.18.6.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Collins P., Bauer D. J. Relative potencies of anti-herpes compounds. Ann N Y Acad Sci. 1977 Mar 4;284:49–59. doi: 10.1111/j.1749-6632.1977.tb21936.x. [DOI] [PubMed] [Google Scholar]
  6. Dargan D. J., Subak-Sharpe J. H. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication. J Gen Virol. 1985 Aug;66(Pt 8):1771–1784. doi: 10.1099/0022-1317-66-8-1771. [DOI] [PubMed] [Google Scholar]
  7. Field A. K., Davies M. E., DeWitt C. M., Perry H. C., Schofield T. L., Karkas J. D., Germershausen J., Wagner A. F., Cantone C. L., MacCoss M. Efficacy of 2'-nor-cyclicGMP in treatment of experimental herpes virus infections. Antiviral Res. 1986 Oct;6(6):329–341. doi: 10.1016/0166-3542(86)90015-x. [DOI] [PubMed] [Google Scholar]
  8. Fong C. K., Cohen S. D., McCormick S., Hsiung G. D. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model. Antiviral Res. 1987 Jan;7(1):11–23. doi: 10.1016/0166-3542(87)90035-0. [DOI] [PubMed] [Google Scholar]
  9. Gonzalez-Serva A., Hsiung G. D. Expression of herpesvirus in adherent cells derived from bone marrow of latently infected guinea pigs. Am J Pathol. 1978 Jun;91(3):483–496. [PMC free article] [PubMed] [Google Scholar]
  10. Griffith B. P., Hsiung G. D. Persistence and expression of herpes virus in guinea pig B and T spleen cells. Proc Soc Exp Biol Med. 1979 Oct;162(1):202–206. doi: 10.3181/00379727-162-40647. [DOI] [PubMed] [Google Scholar]
  11. Harmenberg J., Wahren B., Oberg B. Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology. 1980;14(5-6):239–244. doi: 10.1159/000149192. [DOI] [PubMed] [Google Scholar]
  12. Hsiung G. D., Bia F. J., Fong C. K. Viruses of guinea pigs: considerations for biomedical research. Microbiol Rev. 1980 Sep;44(3):468–490. doi: 10.1128/mr.44.3.468-490.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hsiung G. D., Fong C. K., Lam K. M. In vitro transformation of leukocytes with a guinea pig herpes-like virus. Bibl Haematol. 1973;39:401–409. doi: 10.1159/000427869. [DOI] [PubMed] [Google Scholar]
  14. Hsiung G. D., Fong C. R., Lam K. M. Guinea pig leukocytes: in vivo and in vitro infection with a herpes-like virus. J Immunol. 1971 Jan;106(6):1686–1689. [PubMed] [Google Scholar]
  15. Hsiung G. D., Kaplow L. S., Booss J. Herpesvirus infection of guinea pigs. I. Isolation, characterization and pathogenicity. Am J Epidemiol. 1971 Apr;93(4):298–307. doi: 10.1093/oxfordjournals.aje.a121261. [DOI] [PubMed] [Google Scholar]
  16. Hsiung G. D., Kaplow L. S. Herpeslike virus isolated from spontaneously degenerated tissue culture derived from leukemia-susceptible guinea pigs. J Virol. 1969 Mar;3(3):355–357. doi: 10.1128/jvi.3.3.355-357.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hsiung G. D. Virological studies of guinea pig leukemia: an overview with reference to herpesvirus and oncornavirus. Fed Proc. 1977 Aug;36(9):2285–2289. [PubMed] [Google Scholar]
  18. Sauer G., Amtmann E., Melber K., Knapp A., Müller K., Hummel K., Scherm A. DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3263–3267. doi: 10.1073/pnas.81.11.3263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shigeta S., Konno K., Yokota T., Nakamura K., De Clercq E. Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro. Antimicrob Agents Chemother. 1988 Jun;32(6):906–911. doi: 10.1128/aac.32.6.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tenser R. B., Hsiung G. D. Infection of thymus cells in vivo and in vitro with a guinea pig herpes-like virus and the effect of antibody on virus replication in organ culture. J Immunol. 1973 Feb;110(2):552–560. [PubMed] [Google Scholar]
  21. Tolman R. L., Field A. K., Karkas J. D., Wagner A. F., Germershausen J., Crumpacker C., Scolnick E. M. 2'-Nor-cGMP: a seco-cyclic nucleotide with powerful anti-DNA-viral activity. Biochem Biophys Res Commun. 1985 May 16;128(3):1329–1335. doi: 10.1016/0006-291x(85)91086-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES